Literature DB >> 17064910

1-Methylpyridinium-4-(4-phenylmethanethiosulfonate) iodide, MTS-MPP+, a novel scanning cysteine accessibility method (SCAM) reagent for monoamine transporter studies.

Alejandra Gallardo-Godoy1, Melissa I Torres-Altoro, Kellie J White, Eric L Barker, David E Nichols.   

Abstract

A novel substituted cysteine accessibility method (SCAM) reagent was developed for monoamine uptake transporters. The new reagent, MTS-MPP(+), was a derivative of the neurotoxin and transporter substrate MPP(+). MTS-MPP(+) labeled cysteine residues introduced into the serotonin transporter protein. Although it did not prove to be a substrate, as is MPP(+), it appears to label cysteine residues lining the permeation pore of the transporter more readily than currently available nonspecific SCAM reagents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064910      PMCID: PMC1764826          DOI: 10.1016/j.bmc.2006.09.058

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  20 in total

1.  The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.

Authors:  L Shi; M M Simpson; J A Ballesteros; J A Javitch
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

2.  Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors.

Authors:  Jonathan A Javitch; Lei Shi; George Liapakis
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

3.  Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA.

Authors:  S Kitayama; S Shimada; G R Uhl
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

4.  Methyl-4-phenylpyridinium (MPP(+))-evoked dopamine release from rat striatal slices: possible roles of voltage-dependent calcium channels and reverse dopamine transport.

Authors:  M Inazu; N Kubota; H Takeda; K Oguchi; M Koizumi; S Kimura; T Matsumiya
Journal:  Neurochem Int       Date:  2001-09       Impact factor: 3.921

5.  The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.

Authors:  J A Javitch; L Shi; M M Simpson; J Chen; V Chiappa; I Visiers; H Weinstein; J A Ballesteros
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

6.  Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I.

Authors:  L Keith Henry; Erika M Adkins; Qiao Han; Randy D Blakely
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

7.  Conducting states of a mammalian serotonin transporter.

Authors:  S Mager; C Min; D J Henry; C Chavkin; B J Hoffman; N Davidson; H A Lester
Journal:  Neuron       Date:  1994-04       Impact factor: 17.173

8.  Rates of thiol-disulfide interchange reactions involving proteins and kinetic measurements of thiol pKa values.

Authors:  Z Shaked; R P Szajewski; G M Whitesides
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

9.  Uptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: comparison with 5-hydroxytryptamine.

Authors:  F Martel; E Keating
Journal:  Placenta       Date:  2003-04       Impact factor: 3.481

Review 10.  Regulation of dopamine and MPP+ transport by catecholamine transporters.

Authors:  Toshihiro Dohi; Shigeo Kitayama; Norimitsu Morioka; Kei Kumagai; Chieko Mitsuhata; Katsuya Morita; Katsuyuki Kozai; Zhicheng Lin; George R Uhl
Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi       Date:  2004-04
View more
  1 in total

1.  Helix XI contributes to the entrance of the serotonin transporter permeation pathway.

Authors:  Melissa I Torres-Altoro; Kellie J White; Gustavo J Rodríguez; David E Nichols; Eric L Barker
Journal:  Protein Sci       Date:  2008-07-15       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.